ABSTRACT
Vasopressin V2 receptors, expressed from an x-chromosomal gene, are involved in antidiuresis, but also in release of coagulation factor VIII and von Willebrand factor (vWF). The present study describes autosomal recessive nephrogenic diabetes insipidus (NDI) in a large cluster of patients in Isra e li Lower-Galilee. Evidence for an intact V2 receptor was concluded by their normal increase in factor VIII and vWF after desmopressin infusion. Thus, in these patients a defect in the pathway beyond the V2 receptor was suspected. The recent cloning of the human Aquaporin-2 gene enabled us to test this gene as a candidate for such a postreceptor defect. Direct sequencing of the V ASOPRESSIN exerts its effects through stim ulation of at least tw o types of receptors: V u receptors m ediate the pressor response of this hormone and other actions, such as glycogenolysis and platelet aggregation. V2 receptors are involved in antidiuresis, but also in release of coagulation factor VIII, von Willebrand factor (vWF), and tissue-type plasminogen activator (t-PA) (1). M utations in the x-chromosomal V2 receptor result in X-linked nephrogenic diabetes insipidus (NDI) (2, 3). Biochemically, the V2 receptor defect of X-linked NDI is reflected by a blunted antidiuretic re sponse to the V 2 receptor agonist desm opressin. Moreover, patients with X-linked NDI do not sh ow an increase of co agulation and fibrinolytic factors to desm opressin adm inis tration (4). The X-linked type of N D I is the m ost frequent form of the disease, but som e families have been described in which NDI show s an autosomal recessive m ode of inher itance. In previous studies, w e have found evidence for an intact V2 receptor in four NDI patients, as concluded by their normal increase in factor VIII and vWF after desm opressin infusion (5,6). Thus, in these patients a defect in the pathw ay beyond the V2 receptor was suspected.
By screening kidney cD N A and cosm id libraries w ith a rat Aquaporin-2 cD NA as a probe, the hum an Aquaporin-2 (AQP2) gene was identified, assigned to chrom osom e 12, and found to be mutated in a patient w ith autosom al recessive NDI (7). Subsequently, three additional N D I fam ilies w ith mutations in the AQP2 gene have been reported (8). Received M ay 21,1996 . Revision received A u g u st 5,1996. Re-revision received October 10, 1996. Accepted N ovem ber 7, 1996.
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Aquaporin-2 gene revealed a G298T substitution causing a GlylOOStop nonsense mutation in the third transmembrane region. Because this putative disease-causing m utation was identified in index patients of different families, we suggest th a t all patients are descendants of a common ancestor. Thus, this new entity is charac terized by an autosomal recessive NDI. The differential response of clotting factors and urine osmolality to desmopressin may provide a simple tool for clinical diagnosis of a V2-postreceptor defect. The early stop-codon of Aquaporin-2 results in complete resistance to vasopres sin antidiuretic effect. (J Clin Endocrinol Metab 82: 686-689,1997) The present study describes autosom al recessive NDI in a large cluster of patients in Israel's Lower-Galilee. We have identified a new m utation in the AQP2 gene. Because this pxxtative disease-causing mutation was identified in index patients of different families, w e suggest that all patients are descendants of a com m on ancestor.
Subjects and M ethods
The pedigrees of the patients are depicted in Fig. 1 . The families are of Bedouin-Arab origin, w here first cousin m arriage is traditional. Al though w e have n o t been able to trace the relationship of these families w ith each other, such relation can b e assum ed to exist as members of these three families live w ithin an area of 20 km.
Presenting w ith neonatal fever and vom iting (6/11 patients) or failure to thrive (4/11 patients), N D I w as diagnosed by dem onstration of poly uria of 161-250 m L /k g /d a y , low u rin ary osm olality, w ith maximal concentration to 52-102 m O sm /k g , h ig h sim ultaneous plasm a osmola lity of 296-326 m O sm /k g , an d serum so d iu m concentration of 147-168 m E q /L and lack of response to vasopressin. The clinical picture was also characterized by fetal distress (3/5 patients), short stature with a mean height of -1.05 su, slow psychom otor developm ent and mental retar dation (6/11 patients), and psychosis in one patient, w ho presented with extrem e and aggressive anger at night, w hich m ight have been related to thirst.
Two pairs of the obligatory heterozygous p arents of affected patients w ere screened for a possible concentration defect. Their fasting serum sodium (139-142 m E q/L ) urine osm olality (780-940 m O sm /kg) was norm al, as w ere the 24-h urine volum es (21-29 m L /k g /d ) . 
Desmopressin infusion test

Coagulation factors
Factor VIII activity was measured by a single-stage assay, as previ ously reported (9). The normal range in 30 healthy controls was 50-150 U/dL. vWF antigen was measured by an enzyme-immunoassay (10), with reagents purchased from Stago (Asnieres, France).
Mutation analysis
Chromosomal DNA was isolated from blood using the salt ex traction method (11). Amplification of 100 ng of genomic DNA was performed in 100 /xL, using primers flanking exon 1 of the AQP2 gene. After purification of the polymerase chain reaction (PCR) product, the same primers were used to sequence both strands in the cycle se quencing reaction with the fluorescence-based Applied Biosystems model 373A DNA-sequencing system (7). Restriction mapping of the crude exon I PCR product was carried out with Ms pi, and the di gestion products were resolved on 2% agarose and visualized with ethidiumbromide.
Results
In Fig. 2, the results 
